0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Recombinant Protein Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-9U17285
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gene Recombinant Protein Market Research Report 2024
BUY CHAPTERS

Global Gene Recombinant Protein Market Research Report 2024

Code: QYRE-Auto-9U17285
Report
May 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gene Recombinant Protein Market

Genetically recombinant protein is a protein produced using genetic engineering technology.
The global Gene Recombinant Protein market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Gene Recombinant Protein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gene Recombinant Protein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Gene Recombinant Protein in Pharmaceutical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Gene Recombinant Protein include Thermo Fisher Scientific, Eurogentec, GenScript, OriGene, Sino Biological, Abgenex, Promega, Bio - Techne, Merck KGaA, Abcam PLC, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gene Recombinant Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Recombinant Protein.
The Gene Recombinant Protein market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Recombinant Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Recombinant Protein companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gene Recombinant Protein Market Report

Report Metric Details
Report Name Gene Recombinant Protein Market
Segment by Type
  • Cytokines
  • Plasma Protein Factors
  • Recombinant Hormone
  • Interferon
  • Growth Factors
  • Clotting Factor
  • Enzyme
  • Others
Segment by Application
  • Pharmaceutical
  • Scientific Research
  • Cosmetic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Eurogentec, GenScript, OriGene, Sino Biological, Abgenex, Promega, Bio - Techne, Merck KGaA, Abcam PLC, Cytiva, Abnova Corporation, Ajinomoto, Miltenyi Biotec, Bio-Techne Corporation, ACROBiosystems, Reprocell, BPS Bioscience, ProSpec Tany TechnoGene
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gene Recombinant Protein company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Recombinant Protein Market report?

Ans: The main players in the Gene Recombinant Protein Market are Thermo Fisher Scientific, Eurogentec, GenScript, OriGene, Sino Biological, Abgenex, Promega, Bio - Techne, Merck KGaA, Abcam PLC, Cytiva, Abnova Corporation, Ajinomoto, Miltenyi Biotec, Bio-Techne Corporation, ACROBiosystems, Reprocell, BPS Bioscience, ProSpec Tany TechnoGene

What are the Application segmentation covered in the Gene Recombinant Protein Market report?

Ans: The Applications covered in the Gene Recombinant Protein Market report are Pharmaceutical, Scientific Research, Cosmetic, Others

What are the Type segmentation covered in the Gene Recombinant Protein Market report?

Ans: The Types covered in the Gene Recombinant Protein Market report are Cytokines, Plasma Protein Factors, Recombinant Hormone, Interferon, Growth Factors, Clotting Factor, Enzyme, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Recombinant Protein Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cytokines
1.2.3 Plasma Protein Factors
1.2.4 Recombinant Hormone
1.2.5 Interferon
1.2.6 Growth Factors
1.2.7 Clotting Factor
1.2.8 Enzyme
1.2.9 Others
1.3 Market by Application
1.3.1 Global Gene Recombinant Protein Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical
1.3.3 Scientific Research
1.3.4 Cosmetic
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Recombinant Protein Market Perspective (2019-2030)
2.2 Global Gene Recombinant Protein Growth Trends by Region
2.2.1 Global Gene Recombinant Protein Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Recombinant Protein Historic Market Size by Region (2019-2024)
2.2.3 Gene Recombinant Protein Forecasted Market Size by Region (2025-2030)
2.3 Gene Recombinant Protein Market Dynamics
2.3.1 Gene Recombinant Protein Industry Trends
2.3.2 Gene Recombinant Protein Market Drivers
2.3.3 Gene Recombinant Protein Market Challenges
2.3.4 Gene Recombinant Protein Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Recombinant Protein Players by Revenue
3.1.1 Global Top Gene Recombinant Protein Players by Revenue (2019-2024)
3.1.2 Global Gene Recombinant Protein Revenue Market Share by Players (2019-2024)
3.2 Global Gene Recombinant Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Recombinant Protein Revenue
3.4 Global Gene Recombinant Protein Market Concentration Ratio
3.4.1 Global Gene Recombinant Protein Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Recombinant Protein Revenue in 2023
3.5 Global Key Players of Gene Recombinant Protein Head office and Area Served
3.6 Global Key Players of Gene Recombinant Protein, Product and Application
3.7 Global Key Players of Gene Recombinant Protein, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Recombinant Protein Breakdown Data by Type
4.1 Global Gene Recombinant Protein Historic Market Size by Type (2019-2024)
4.2 Global Gene Recombinant Protein Forecasted Market Size by Type (2025-2030)
5 Gene Recombinant Protein Breakdown Data by Application
5.1 Global Gene Recombinant Protein Historic Market Size by Application (2019-2024)
5.2 Global Gene Recombinant Protein Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Recombinant Protein Market Size (2019-2030)
6.2 North America Gene Recombinant Protein Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Recombinant Protein Market Size by Country (2019-2024)
6.4 North America Gene Recombinant Protein Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Recombinant Protein Market Size (2019-2030)
7.2 Europe Gene Recombinant Protein Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Recombinant Protein Market Size by Country (2019-2024)
7.4 Europe Gene Recombinant Protein Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Recombinant Protein Market Size (2019-2030)
8.2 Asia-Pacific Gene Recombinant Protein Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Recombinant Protein Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Recombinant Protein Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Recombinant Protein Market Size (2019-2030)
9.2 Latin America Gene Recombinant Protein Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Recombinant Protein Market Size by Country (2019-2024)
9.4 Latin America Gene Recombinant Protein Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Recombinant Protein Market Size (2019-2030)
10.2 Middle East & Africa Gene Recombinant Protein Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Recombinant Protein Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Recombinant Protein Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Gene Recombinant Protein Introduction
11.1.4 Thermo Fisher Scientific Revenue in Gene Recombinant Protein Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Eurogentec
11.2.1 Eurogentec Company Details
11.2.2 Eurogentec Business Overview
11.2.3 Eurogentec Gene Recombinant Protein Introduction
11.2.4 Eurogentec Revenue in Gene Recombinant Protein Business (2019-2024)
11.2.5 Eurogentec Recent Development
11.3 GenScript
11.3.1 GenScript Company Details
11.3.2 GenScript Business Overview
11.3.3 GenScript Gene Recombinant Protein Introduction
11.3.4 GenScript Revenue in Gene Recombinant Protein Business (2019-2024)
11.3.5 GenScript Recent Development
11.4 OriGene
11.4.1 OriGene Company Details
11.4.2 OriGene Business Overview
11.4.3 OriGene Gene Recombinant Protein Introduction
11.4.4 OriGene Revenue in Gene Recombinant Protein Business (2019-2024)
11.4.5 OriGene Recent Development
11.5 Sino Biological
11.5.1 Sino Biological Company Details
11.5.2 Sino Biological Business Overview
11.5.3 Sino Biological Gene Recombinant Protein Introduction
11.5.4 Sino Biological Revenue in Gene Recombinant Protein Business (2019-2024)
11.5.5 Sino Biological Recent Development
11.6 Abgenex
11.6.1 Abgenex Company Details
11.6.2 Abgenex Business Overview
11.6.3 Abgenex Gene Recombinant Protein Introduction
11.6.4 Abgenex Revenue in Gene Recombinant Protein Business (2019-2024)
11.6.5 Abgenex Recent Development
11.7 Promega
11.7.1 Promega Company Details
11.7.2 Promega Business Overview
11.7.3 Promega Gene Recombinant Protein Introduction
11.7.4 Promega Revenue in Gene Recombinant Protein Business (2019-2024)
11.7.5 Promega Recent Development
11.8 Bio - Techne
11.8.1 Bio - Techne Company Details
11.8.2 Bio - Techne Business Overview
11.8.3 Bio - Techne Gene Recombinant Protein Introduction
11.8.4 Bio - Techne Revenue in Gene Recombinant Protein Business (2019-2024)
11.8.5 Bio - Techne Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Gene Recombinant Protein Introduction
11.9.4 Merck KGaA Revenue in Gene Recombinant Protein Business (2019-2024)
11.9.5 Merck KGaA Recent Development
11.10 Abcam PLC
11.10.1 Abcam PLC Company Details
11.10.2 Abcam PLC Business Overview
11.10.3 Abcam PLC Gene Recombinant Protein Introduction
11.10.4 Abcam PLC Revenue in Gene Recombinant Protein Business (2019-2024)
11.10.5 Abcam PLC Recent Development
11.11 Cytiva
11.11.1 Cytiva Company Details
11.11.2 Cytiva Business Overview
11.11.3 Cytiva Gene Recombinant Protein Introduction
11.11.4 Cytiva Revenue in Gene Recombinant Protein Business (2019-2024)
11.11.5 Cytiva Recent Development
11.12 Abnova Corporation
11.12.1 Abnova Corporation Company Details
11.12.2 Abnova Corporation Business Overview
11.12.3 Abnova Corporation Gene Recombinant Protein Introduction
11.12.4 Abnova Corporation Revenue in Gene Recombinant Protein Business (2019-2024)
11.12.5 Abnova Corporation Recent Development
11.13 Ajinomoto
11.13.1 Ajinomoto Company Details
11.13.2 Ajinomoto Business Overview
11.13.3 Ajinomoto Gene Recombinant Protein Introduction
11.13.4 Ajinomoto Revenue in Gene Recombinant Protein Business (2019-2024)
11.13.5 Ajinomoto Recent Development
11.14 Miltenyi Biotec
11.14.1 Miltenyi Biotec Company Details
11.14.2 Miltenyi Biotec Business Overview
11.14.3 Miltenyi Biotec Gene Recombinant Protein Introduction
11.14.4 Miltenyi Biotec Revenue in Gene Recombinant Protein Business (2019-2024)
11.14.5 Miltenyi Biotec Recent Development
11.15 Bio-Techne Corporation
11.15.1 Bio-Techne Corporation Company Details
11.15.2 Bio-Techne Corporation Business Overview
11.15.3 Bio-Techne Corporation Gene Recombinant Protein Introduction
11.15.4 Bio-Techne Corporation Revenue in Gene Recombinant Protein Business (2019-2024)
11.15.5 Bio-Techne Corporation Recent Development
11.16 ACROBiosystems
11.16.1 ACROBiosystems Company Details
11.16.2 ACROBiosystems Business Overview
11.16.3 ACROBiosystems Gene Recombinant Protein Introduction
11.16.4 ACROBiosystems Revenue in Gene Recombinant Protein Business (2019-2024)
11.16.5 ACROBiosystems Recent Development
11.17 Reprocell
11.17.1 Reprocell Company Details
11.17.2 Reprocell Business Overview
11.17.3 Reprocell Gene Recombinant Protein Introduction
11.17.4 Reprocell Revenue in Gene Recombinant Protein Business (2019-2024)
11.17.5 Reprocell Recent Development
11.18 BPS Bioscience
11.18.1 BPS Bioscience Company Details
11.18.2 BPS Bioscience Business Overview
11.18.3 BPS Bioscience Gene Recombinant Protein Introduction
11.18.4 BPS Bioscience Revenue in Gene Recombinant Protein Business (2019-2024)
11.18.5 BPS Bioscience Recent Development
11.19 ProSpec Tany TechnoGene
11.19.1 ProSpec Tany TechnoGene Company Details
11.19.2 ProSpec Tany TechnoGene Business Overview
11.19.3 ProSpec Tany TechnoGene Gene Recombinant Protein Introduction
11.19.4 ProSpec Tany TechnoGene Revenue in Gene Recombinant Protein Business (2019-2024)
11.19.5 ProSpec Tany TechnoGene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Gene Recombinant Protein Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Cytokines
 Table 3. Key Players of Plasma Protein Factors
 Table 4. Key Players of Recombinant Hormone
 Table 5. Key Players of Interferon
 Table 6. Key Players of Growth Factors
 Table 7. Key Players of Clotting Factor
 Table 8. Key Players of Enzyme
 Table 9. Global Gene Recombinant Protein Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 10. Global Gene Recombinant Protein Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 11. Global Gene Recombinant Protein Market Size by Region (2019-2024) & (US$ Million)
 Table 12. Global Gene Recombinant Protein Market Share by Region (2019-2024)
 Table 13. Global Gene Recombinant Protein Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 14. Global Gene Recombinant Protein Market Share by Region (2025-2030)
 Table 15. Gene Recombinant Protein Market Trends
 Table 16. Gene Recombinant Protein Market Drivers
 Table 17. Gene Recombinant Protein Market Challenges
 Table 18. Gene Recombinant Protein Market Restraints
 Table 19. Global Gene Recombinant Protein Revenue by Players (2019-2024) & (US$ Million)
 Table 20. Global Gene Recombinant Protein Market Share by Players (2019-2024)
 Table 21. Global Top Gene Recombinant Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Recombinant Protein as of 2023)
 Table 22. Ranking of Global Top Gene Recombinant Protein Companies by Revenue (US$ Million) in 2023
 Table 23. Global 5 Largest Players Market Share by Gene Recombinant Protein Revenue (CR5 and HHI) & (2019-2024)
 Table 24. Global Key Players of Gene Recombinant Protein, Headquarters and Area Served
 Table 25. Global Key Players of Gene Recombinant Protein, Product and Application
 Table 26. Global Key Players of Gene Recombinant Protein, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Gene Recombinant Protein Market Size by Type (2019-2024) & (US$ Million)
 Table 29. Global Gene Recombinant Protein Revenue Market Share by Type (2019-2024)
 Table 30. Global Gene Recombinant Protein Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 31. Global Gene Recombinant Protein Revenue Market Share by Type (2025-2030)
 Table 32. Global Gene Recombinant Protein Market Size by Application (2019-2024) & (US$ Million)
 Table 33. Global Gene Recombinant Protein Revenue Market Share by Application (2019-2024)
 Table 34. Global Gene Recombinant Protein Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 35. Global Gene Recombinant Protein Revenue Market Share by Application (2025-2030)
 Table 36. North America Gene Recombinant Protein Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 37. North America Gene Recombinant Protein Market Size by Country (2019-2024) & (US$ Million)
 Table 38. North America Gene Recombinant Protein Market Size by Country (2025-2030) & (US$ Million)
 Table 39. Europe Gene Recombinant Protein Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 40. Europe Gene Recombinant Protein Market Size by Country (2019-2024) & (US$ Million)
 Table 41. Europe Gene Recombinant Protein Market Size by Country (2025-2030) & (US$ Million)
 Table 42. Asia-Pacific Gene Recombinant Protein Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Asia-Pacific Gene Recombinant Protein Market Size by Region (2019-2024) & (US$ Million)
 Table 44. Asia-Pacific Gene Recombinant Protein Market Size by Region (2025-2030) & (US$ Million)
 Table 45. Latin America Gene Recombinant Protein Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 46. Latin America Gene Recombinant Protein Market Size by Country (2019-2024) & (US$ Million)
 Table 47. Latin America Gene Recombinant Protein Market Size by Country (2025-2030) & (US$ Million)
 Table 48. Middle East & Africa Gene Recombinant Protein Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 49. Middle East & Africa Gene Recombinant Protein Market Size by Country (2019-2024) & (US$ Million)
 Table 50. Middle East & Africa Gene Recombinant Protein Market Size by Country (2025-2030) & (US$ Million)
 Table 51. Thermo Fisher Scientific Company Details
 Table 52. Thermo Fisher Scientific Business Overview
 Table 53. Thermo Fisher Scientific Gene Recombinant Protein Product
 Table 54. Thermo Fisher Scientific Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 55. Thermo Fisher Scientific Recent Development
 Table 56. Eurogentec Company Details
 Table 57. Eurogentec Business Overview
 Table 58. Eurogentec Gene Recombinant Protein Product
 Table 59. Eurogentec Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 60. Eurogentec Recent Development
 Table 61. GenScript Company Details
 Table 62. GenScript Business Overview
 Table 63. GenScript Gene Recombinant Protein Product
 Table 64. GenScript Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 65. GenScript Recent Development
 Table 66. OriGene Company Details
 Table 67. OriGene Business Overview
 Table 68. OriGene Gene Recombinant Protein Product
 Table 69. OriGene Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 70. OriGene Recent Development
 Table 71. Sino Biological Company Details
 Table 72. Sino Biological Business Overview
 Table 73. Sino Biological Gene Recombinant Protein Product
 Table 74. Sino Biological Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 75. Sino Biological Recent Development
 Table 76. Abgenex Company Details
 Table 77. Abgenex Business Overview
 Table 78. Abgenex Gene Recombinant Protein Product
 Table 79. Abgenex Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 80. Abgenex Recent Development
 Table 81. Promega Company Details
 Table 82. Promega Business Overview
 Table 83. Promega Gene Recombinant Protein Product
 Table 84. Promega Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 85. Promega Recent Development
 Table 86. Bio - Techne Company Details
 Table 87. Bio - Techne Business Overview
 Table 88. Bio - Techne Gene Recombinant Protein Product
 Table 89. Bio - Techne Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 90. Bio - Techne Recent Development
 Table 91. Merck KGaA Company Details
 Table 92. Merck KGaA Business Overview
 Table 93. Merck KGaA Gene Recombinant Protein Product
 Table 94. Merck KGaA Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 95. Merck KGaA Recent Development
 Table 96. Abcam PLC Company Details
 Table 97. Abcam PLC Business Overview
 Table 98. Abcam PLC Gene Recombinant Protein Product
 Table 99. Abcam PLC Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 100. Abcam PLC Recent Development
 Table 101. Cytiva Company Details
 Table 102. Cytiva Business Overview
 Table 103. Cytiva Gene Recombinant Protein Product
 Table 104. Cytiva Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 105. Cytiva Recent Development
 Table 106. Abnova Corporation Company Details
 Table 107. Abnova Corporation Business Overview
 Table 108. Abnova Corporation Gene Recombinant Protein Product
 Table 109. Abnova Corporation Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 110. Abnova Corporation Recent Development
 Table 111. Ajinomoto Company Details
 Table 112. Ajinomoto Business Overview
 Table 113. Ajinomoto Gene Recombinant Protein Product
 Table 114. Ajinomoto Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 115. Ajinomoto Recent Development
 Table 116. Miltenyi Biotec Company Details
 Table 117. Miltenyi Biotec Business Overview
 Table 118. Miltenyi Biotec Gene Recombinant Protein Product
 Table 119. Miltenyi Biotec Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 120. Miltenyi Biotec Recent Development
 Table 121. Bio-Techne Corporation Company Details
 Table 122. Bio-Techne Corporation Business Overview
 Table 123. Bio-Techne Corporation Gene Recombinant Protein Product
 Table 124. Bio-Techne Corporation Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 125. Bio-Techne Corporation Recent Development
 Table 126. ACROBiosystems Company Details
 Table 127. ACROBiosystems Business Overview
 Table 128. ACROBiosystems Gene Recombinant Protein Product
 Table 129. ACROBiosystems Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 130. ACROBiosystems Recent Development
 Table 131. Reprocell Company Details
 Table 132. Reprocell Business Overview
 Table 133. Reprocell Gene Recombinant Protein Product
 Table 134. Reprocell Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 135. Reprocell Recent Development
 Table 136. BPS Bioscience Company Details
 Table 137. BPS Bioscience Business Overview
 Table 138. BPS Bioscience Gene Recombinant Protein Product
 Table 139. BPS Bioscience Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 140. BPS Bioscience Recent Development
 Table 141. ProSpec Tany TechnoGene Company Details
 Table 142. ProSpec Tany TechnoGene Business Overview
 Table 143. ProSpec Tany TechnoGene Gene Recombinant Protein Product
 Table 144. ProSpec Tany TechnoGene Revenue in Gene Recombinant Protein Business (2019-2024) & (US$ Million)
 Table 145. ProSpec Tany TechnoGene Recent Development
 Table 146. Research Programs/Design for This Report
 Table 147. Key Data Information from Secondary Sources
 Table 148. Key Data Information from Primary Sources
 Table 149. Authors List of This Report


List of Figures
 Figure 1. Gene Recombinant Protein Picture
 Figure 2. Global Gene Recombinant Protein Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Gene Recombinant Protein Market Share by Type: 2023 VS 2030
 Figure 4. Cytokines Features
 Figure 5. Plasma Protein Factors Features
 Figure 6. Recombinant Hormone Features
 Figure 7. Interferon Features
 Figure 8. Growth Factors Features
 Figure 9. Clotting Factor Features
 Figure 10. Enzyme Features
 Figure 11. Others Features
 Figure 12. Global Gene Recombinant Protein Market Size by Application (2024-2030) & (US$ Million)
 Figure 13. Global Gene Recombinant Protein Market Share by Application: 2023 VS 2030
 Figure 14. Pharmaceutical Case Studies
 Figure 15. Scientific Research Case Studies
 Figure 16. Cosmetic Case Studies
 Figure 17. Others Case Studies
 Figure 18. Gene Recombinant Protein Report Years Considered
 Figure 19. Global Gene Recombinant Protein Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 20. Global Gene Recombinant Protein Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 21. Global Gene Recombinant Protein Market Share by Region: 2023 VS 2030
 Figure 22. Global Gene Recombinant Protein Market Share by Players in 2023
 Figure 23. Global Top Gene Recombinant Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Recombinant Protein as of 2023)
 Figure 24. The Top 10 and 5 Players Market Share by Gene Recombinant Protein Revenue in 2023
 Figure 25. North America Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. North America Gene Recombinant Protein Market Share by Country (2019-2030)
 Figure 27. United States Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Canada Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Europe Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Europe Gene Recombinant Protein Market Share by Country (2019-2030)
 Figure 31. Germany Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. France Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. U.K. Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Italy Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Russia Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Nordic Countries Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Asia-Pacific Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Asia-Pacific Gene Recombinant Protein Market Share by Region (2019-2030)
 Figure 39. China Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Japan Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. South Korea Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. India Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Australia Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Latin America Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Latin America Gene Recombinant Protein Market Share by Country (2019-2030)
 Figure 47. Mexico Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. Brazil Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Middle East & Africa Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 50. Middle East & Africa Gene Recombinant Protein Market Share by Country (2019-2030)
 Figure 51. Turkey Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 53. UAE Gene Recombinant Protein Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 55. Eurogentec Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 56. GenScript Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 57. OriGene Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 58. Sino Biological Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 59. Abgenex Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 60. Promega Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 61. Bio - Techne Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 62. Merck KGaA Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 63. Abcam PLC Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 64. Cytiva Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 65. Abnova Corporation Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 66. Ajinomoto Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 67. Miltenyi Biotec Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 68. Bio-Techne Corporation Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 69. ACROBiosystems Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 70. Reprocell Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 71. BPS Bioscience Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 72. ProSpec Tany TechnoGene Revenue Growth Rate in Gene Recombinant Protein Business (2019-2024)
 Figure 73. Bottom-up and Top-down Approaches for This Report
 Figure 74. Data Triangulation
 Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS